Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTPCytopenia, Hemic and Lymphatic Diseases, Hemorrhage, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, acquired thrombotic thrombocytopenic purpura, blood coagulation disease, blood platelet disease, hematologic disorder, purpura, thrombocytopenia, thrombocytopenic purpura, thrombophilia, thrombotic microangiopathy, thrombotic thrombocytopenic purpuraActive, not recruitingNot stated2026-04-30NCT04985318

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
University of Cologne43

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
University Hospital of CologneCologneGermany6